Leaders in Health and Human Services Reporting
Previous meetings have made alternative arrangements like phone-in capability or have been canceled. These meetings are on the calendar as of today. July 30, 2020 This meeting will be webcast: Newborn…
Read more
The Joint Committee on Access and Forensic Services develops recommendations for the bed day allocation methodology, the bed day utilization review protocol including a peer review process and advises on a comprehensive…
Read more
House Bill (HB) 1874, 84th Legislature, Regular Session, 2015 established the Palliative Care Interdisciplinary Advisory Council to assess the availability of patient-centered and family-focused palliative care in Texas. HB 1874 charges…
Read more
Previous meetings have made alternative arrangements like phone-in capability or have been canceled. These meetings are on the calendar as of today. July 29, 2020 Joint Committee on Access…
Read more
Texas Insight provides timely reporting of healthcare issues and events as they occur within the legislative and regulatory branches of Texas state government. Health Resources and Services Administration (HRSA): CARES Act Medicaid, CHIP, Dental…
Read more
Previous meetings have made alternative arrangements like phone-in capability or have been canceled. These meetings are on the calendar as of today. July 27, 2020 Emergency Medical Services Committee Meeting…
Read more
The Texas Autism Council advises and makes recommendations to state agencies and the state Legislature to ensure that the needs of persons of all ages with autism and other pervasive developmental…
Read more
Provider Relief Fund Overview In April, HRSA issued a Medicare-focused general distribution of $50 billion for provider relief, allocating 2% of gross revenue regardless of payor mix to eligible providers.…
Read more
Previous meetings have made alternative arrangements like phone-in capability or have been canceled. These meetings are on the calendar as of today. July 27, 2020 Emergency Medical Services Committee Meeting…
Read more
The Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs.
The DUR board is composed of 20 total members: 18 physicians and pharmacists providing services across the entire population of Medicaid and representing different specialties; two representatives from Medicaid managed care organizations as nonvoting members; and a consumer advocate representing people enrolled in the program.
Read more